… Proposed management of patients requiring high doses of inhaled corticosteroids
depending on their personal risk of osteoporotic fractures. ∗ To maintain, through diet or …

… was introduced in the early 1970s as the first inhaled corticosteroid (ICS) to show enhanced
topical to … Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of …

… explored the association of the risk of pneumonia in COPD … In subgroup analyses,
pneumonia risk was found to be higher … ICS treatment was linked to an elevated pneumonia risk, …

… Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J …
Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: a …

… may also attenuate airway hyperresponsiveness 11, a known risk factor for morbidity and …
In that study, it was demonstrated that inhaled corticosteroids reduced the risk of hospitalisation …

… , it is unclear to what extent inhaled corticosteroids (ICS) would also affect the clinical
presentation. … Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of …

The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of patients
with chronic obstructive pulmonary disease (COPD) is much debated, since it can result in …

Inhaled corticosteroids (ICS) might reduce the risk of lung cancer by controlling airway
inflammation in patients with chronic obstructive pulmonary disease (COPD) because both are …

… of inhaled corticosteroids lead to an increased risk of glaucoma, cataracts and other problems
associated with oral corticosteroid use. … between inhaled corticosteroids and diabetes. …

… inhaled corticosteroids (ICS) is common in patients with chronic obstructive pulmonary disease
(COPD) and has been associated with an increased risk … if ICS increases the risk of lower …